System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Marek Niedoszytko is an expert in Immunology at University Clinical Centre (Poland). As of October 2026, ScienceLeadR ranks Marek Niedoszytko in the top 1% of experts worldwide for Hypersensitivity. Marek Niedoszytko has authored 220 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 2 of them ongoing. SLR score: 747 (community average: 125). How the SLR is computed.

LeadR Profile

Marek Niedoszytko University Clinical Centre Poland
747 ScienceLeadR Reputation 747

Unlock

Register Login
Network Map

Immunology

Subspecialties: Pulmonology - Hematology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026
Source: PubMed

University of Gdańsk

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 220

Citations

Citations: 5 561 1st author: 23 Last author: 35 Unique author: 1

Main journals

Allergy 26
J Allergy Clin Immunol Pract 23
Clin Transl Allergy 16
Int J Mol Sci 14
Postepy Dermatol Alergol 12

Best Journals

J Hematol Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
As-Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK-air Study.
PMID 42714136 — histamine antagonists, rhinitis, allergic, hypersensitivity, masks, air, rhinitis, therapeutics		Allergy20260
Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.
PMID 42625226 — registries, cells, neoplasms, leukemia, mastocytosis, systemic, transplants, mastocytosis, cell transplantation, transplantation, prognosis		Exp Hematol Oncol20260
ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases.
PMID 42613592 — change management, intelligence, chronic disease, air, rhinitis, asthma, artificial intelligence		Clin Transl Allergy20260
Negative Predictive Value of Allergologic Work-Up with Iodinated Contrast Media in 'Real-Life' Practice.
PMID 42513338 — skin, contrast media, telephone, pharmaceutical preparations, hypersensitivity, drug hypersensitivity, predictive value of tests, skin tests, work, history		J Clin Med20260
Beyond Teleconsultation: Exploring the Role of Mobile Health Technologies in Duchenne Muscular Dystrophy.
PMID 42480073 — muscular dystrophies, monitoring, ambulatory, muscular dystrophy, duchenne, digital health		JMIR Form Res20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 5
Phase 2 1

By status:

Active not recruiting 2
Completed 2
Terminated 2

By type:

Interventional 6

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 6

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Randomized Double Blind Active Controlled Study on Efficacy and Safety of TEV 56248 in Patients with Asthma
2023-505435-12-00 — albuterol, safety, fluticasone, therapeutics, propionates, asthma		Phase 3Active not recruiting2024
Study to assess whether Verekitug can improve the control of Chronic Obstructive Pulmonary Disease (COPD)
2025-520488-42-00 — safety, pulmonary disease, chronic obstructive, lung diseases, lung diseases, obstructive		Phase 2Active not recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS